JD Health International Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from JD Health International Inc.'s yearly results (2022–2025), compared with companies in China. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 71.7 times. Higher than almost all companies in China.
- Debt Due Cover Ratio: Debt due within a year is covered 49.2 times by its yearly operating cash. Higher than 95% of companies in China.
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 86% of companies in China.
Where ¥100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
¥164Over the last 3 years, every ¥100 of reported profit came with ¥164 of operating cash.
Higher than 54% of companies in China.
Self-Funding Ratio
71.7×Over the last 3 years its own operating cash covered its investment spending (capex) 71.7 times.
Higher than almost all companies in China.
Cash Locked Ratio
−¥14Money owed to suppliers is larger than money owed by customers plus stock: ¥14 per ¥100 of sales comes from others' credit, against ¥13 from others' credit three years earlier.
Less money tied up than 77% of companies in China.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 86% of companies in China.
Growth Efficiency Ratio
¥19Sales grew 57% in 3 years; of every extra ¥100 of sales, ¥19 became extra profit.
Higher than 51% of companies in China.
Asset Productivity Ratio
+57% / +33%In 3 years sales changed by +57% while total assets changed by +33%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
49.2×Debt due within a year is covered 49.2 times by its yearly operating cash.
Higher than 95% of companies in China.
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
98%Of every ¥100 the company owns, ¥98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 56% of companies in China.
Tangible Net Worth Ratio
97%Of every ¥100 of net worth, ¥97 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 67% of companies in China.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
JD Health International Inc. owes ¥0.27 for every ¥1 it owns. Net profit rose 29% in the year to Dec 2025, and grew 142% a year on average over 3 years.
Compared with companies in China · latest annual results Dec 2025.
P/E ratio
17.5Investors pay ¥17.5 for every ¥1 of JD Health International Inc.'s yearly profit, higher than 69% of companies in China.
P/B ratio
1.68The share price is 1.68 times JD Health International Inc.'s book value per share, higher than 52% of companies in China.
Market cap
HK$121.1 BThe total market value of all of JD Health International Inc.'s shares at today's price (share price × number of shares), smaller than 61% of companies in China. PosiCap size class: Tito Cap.
Net worth (book value)
¥61.5 BWhat JD Health International Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Return on equity (ROE)
10.4%JD Health International Inc. earned 10.4% on its shareholders' money over the last year, lower than 64% of companies in China.
Owes vs Owns
0.27×JD Health International Inc. owes ¥0.27 for every ¥1 it owns (low), lower than 92% of companies in China.
Dividend yield
NoneJD Health International Inc. does not currently pay a dividend.
Revenue growth
+26%Revenue rose 26% in the year to Dec 2025, and grew 16% a year on average over 3 years.
Profit growth
+29%Net profit rose 29% in the year to Dec 2025, and grew 142% a year on average over 3 years.
Profit margin
7.3%JD Health International Inc. keeps ¥7 of every ¥100 of revenue as net profit.
Cash quality
1.9×Cash from JD Health International Inc.'s business was 1.9× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
355.1×JD Health International Inc.'s operating profit covered its interest costs 355.1 times in the year to Dec 2025.
Cash vs debt
Net cashJD Health International Inc. held ¥47.5 B more cash than debt (net cash) at Dec 2025.
Questions
What is JD Health International Inc.'s P/E ratio?
Investors pay ¥17.5 for every ¥1 of JD Health International Inc.'s yearly profit, higher than 69% of companies in China.
What is JD Health International Inc.'s return on equity?
JD Health International Inc. earned 10.4% on its shareholders' money over the last year, lower than 64% of companies in China.
How much does JD Health International Inc. owe compared with what it owns?
JD Health International Inc. owes ¥0.27 for every ¥1 it owns (low), lower than 92% of companies in China.
Does JD Health International Inc. pay a dividend?
No. JD Health International Inc. does not currently pay a dividend.
Is JD Health International Inc.'s revenue growing?
Revenue rose 26% in the year to Dec 2025, and grew 16% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.